| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | SANGAMO THERAPEUTICS INCORPO | Jul 12, 2024 | |
| Buy | SANGAMO ADR LTD | Dec 13, 2023 | |
| Buy | SANGAMO THERAPEUTICS INC CMN | Aug 23, 2021 | |
| Sell | SANGAMO THERAPEUTICS INC CMN | Apr 20, 2020 | |
| Sell | SANGAMO TECHNOLOGY PLC CMN | Jan 4, 2020 | |
| Buy | SEATTLE GENETICS, INC CMN | Apr 23, 2019 | |
| Sell | SEATTLE GENETICS, INC CMN | Apr 2, 2019 | |
| Buy | Sangamo Therapeutics, Inc. | Jul 20, 2017 | |
| Buy | Sangamo Biosciences | Nov 30, 2016 | |
| Buy | SANGAMO BIOSCIENCES | Mar 2, 2016 |
This page tracks congressional stock trading activity in Sangamo Therapeutics, Inc. (SGMO) in the Healthcare sector. Disclosed Capitol has indexed 12 disclosed congressional trades involving SGMO. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2024 — Disclosed Capitol has tracked 12 disclosed congressional trades in Sangamo Therapeutics, Inc. (SGMO) — 8:4 buy-heavy ratio — led by Ro Khanna (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| 2024-07-12 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2023-12-13 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2021-08-23 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2020-04-20 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2020-01-04 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2019-04-23 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| 2019-04-02 | Ro Khanna | D | Sale | $1,001 - $15,000 |
| 2017-07-20 | Rodney Frelinghuysen | R | Purchase | $1,001 - $15,000 |
| 2016-11-30 | Rodney Frelinghuysen | R | Purchase | $15,001 - $50,000 |
| 2016-03-02 | Rodney Frelinghuysen | R | Purchase | $1,001 - $15,000 |
Across the 12 disclosed congressional trades in Sangamo Therapeutics, Inc. (SGMO), members of Congress have reported 8 buys and 4 sells. The average 30-day alpha vs. the S&P 500 is 7.89%.